calendar
28,909 catalysts · 9,438 approval · 5,000 device 510k · 4,728 grant · 2,952 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
28,909 catalysts · 9,438 approval · 5,000 device 510k · 4,728 grant · 2,952 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: VIATRIS. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: KENVUE BRANDS. Form: AEROSOL, FOAM. Route: TOPICAL
Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL
Sponsor: EXELIXIS. Form: CAPSULE. Route: ORAL
Sponsor: BIOVITRUM AB. Form: VIAL. Route: SUBCUTANEOUS
Sponsor: INDIVIOR. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION
Sponsor: EMERGE BIOSCIENCE. Form: INJECTABLE. Route: INJECTION
Sponsor: BAYER. Form: TABLET. Route: ORAL
Sponsor: SAPTALIS PHARMS. Form: CONCENTRATE. Route: ORAL
Sponsor: OTSUKA PHARM CO LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: SANALUZ. Form: TABLET. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: SPRAY. Route: NASAL
Sponsor: KINIKSA PHARMACEUTICALS (UK), LTD.. Form: VIAL. Route: SINGLE-USE
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: BAYER HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: Lundbeck Seattle BioPharmaceuticals, Inc.. Form: INJECTABLE. Route: INJECTION
Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: INDIVIOR. Form: FILM. Route: BUCCAL, SUBLINGUAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: RECORDATI RARE. Form: TABLET. Route: ORAL